“…Evidence from transgenic models suggests that c-fms encodes for the sole receptor for CSF-1 (Dai et al, 2002). We and others have found that c-fms and/or CSF-1 are expressed by the tumor epithelium in several human epithelial cancers (Kacinski et al, 1988(Kacinski et al, , 1991Rettenmier et al, 1989;Filderman et al, 1992;Ide et al, 2002); elevated levels of c-fms and CSF-1 are associated with poor prognosis (Kacinski et al, 1988;Tang et al, 1990;Price et al, 1993;Chambers et al, 1997Chambers et al, , 2009Scholl et al, 1993;Kluger et al, 2004;Sapi 2004). In human breast cancer, 94% of in situ and invasive lesions express c-fms (Kacinski et al, 1991;Flick et al, 1997), while 36% express both CSF-1 and c-fms (Kacinski et al, 1991;Scholl et al, 1993).…”